6 completed, 4 unknown, 2 terminated, 1 recruiting. 5 Not applicable, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Recruiting 1 |
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Systemic Lupus: new trials by email Literature Review of Systemic Lupus trials Research Report on Systemic Lupus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases Blood sample for genetic analysis, Blood sample for immunological response assessments, Blood sample to identify relevant biomarker of the disease - Systemic Lupus, Autoimmune Diseases | Not applicable | Recruiting | Hospices Civils de Lyon | 400 | 2025-02-26 | 2025-12-22 |
| Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus SRAS-CoV-2 vaccination immunological response - Systemic Lupus | Terminated | University Hospital, Strasbourg, France | 7 | 2021-06-07 | 2025-12-23 | |
| Serum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal Impairment serum ceramides level in blood - Systemic Lupus | Unknown | Assiut University | 90 | 2020-02-01 | 2020-02-17 | |
| SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis Systemic Lupus | Unknown | Assiut University | 60 | 2019-06-01 | 2019-01-15 | |
| Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE blood samples - Systemic Lupus | Unknown | Assiut University | 86 | 2019-03-01 | 2019-01-29 | |
| Immune Adsorption Role in Treatment of Resistant Lupus hemodiafiltration with endogenous re infusion (HFR) - Systemic Lupus | Not applicable | Completed | Dr. Mohamed Ahmed El ghiriani | 90 | 2019-01-01 | 2019-10-01 |
| ASA Patterns for Prevention of Preeclampsia in SLE Pregnancies Patient Educational Tool - Pre-Eclampsia, Pregnancy Complications | Not applicable | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 73 | 2018-05-28 | 2024-03-13 |
| Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus; B / Phuket / 3073/2013-like virus) - Systemic Lupus, Sjogren's Syndrome | Phase 4 | Completed | University of Sao Paulo General Hospital | 300 | 2018-04-23 | 2019-04-26 |
| Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension, Systemic Sclerosis | Unknown | Maastricht University Medical Center | 150 | 2018-03-01 | 2021-09-08 | |
| Yellow Fever Vaccine in Patients With Rheumatic Diseases Yellow Fever vaccine (17D) - Systemic Lupus, Rheumatoid Arthritis | Not applicable | Completed | University of Sao Paulo General Hospital | 600 | 2018-01-31 | 2019-04-26 |
| Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease 13-valent pneumococcal conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine - Rheumatoid Arthritis, Systemic Lupus | Phase 4 | Completed | Region Skane | 300 | 2016-06-14 | 2023-03-29 |
| Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus Social Media - Systemic Lupus | Not applicable | Completed | Milton S. Hershey Medical Center | 37 | 2014-05-01 | 2017-07-14 |
| Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC) Arsenic trioxide - Systemic Lupus | Phase 2 | Terminated | Nantes University Hospital | 11 | 2013-07-01 | 2016-01-06 |
Sjogren's Syndrome (3) · Arthritis, Rheumatoid (2) · Scleroderma, Systemic (2) · Spondylarthritis (2) · Arthritis, Juvenile (1) · Autoimmune Diseases (1) · Dermatomyositis (1) · Genetic Diseases, Inborn (1) · Granulomatosis with Polyangiitis (1) · Mixed Connective Tissue Disease (1) · Myositis (1) · Pneumococcal Infections (1) · Pre-Eclampsia (1) · Pregnancy Complications (1) · Pulmonary Arterial Hypertension (1)
Connective Tissue Diseases (4) · Immune System Diseases (4) · Skin and Connective Tissue Diseases (4) · Arthritis (3) · Autoimmune Diseases (3) · Dry Eye Syndromes (3) · Eye Diseases (3) · Joint Diseases (3) · Lacrimal Apparatus Diseases (3) · Mouth Diseases (3) · Musculoskeletal Diseases (3) · Salivary Gland Diseases (3) · Stomatognathic Diseases (3) · Xerostomia (3) · Bone Diseases (2)
Blood Specimen Collection (3) · 13-valent pneumococcal vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Arsenic Trioxide (1) · Genetic Testing (1) · Hemodiafiltration (1) · Media Exposure (1) · Pneumococcal Vaccines (1) · Yellow Fever Vaccine (1)
Assiut University (3) · University of Sao Paulo General Hospital (2) · Dr. Mohamed Ahmed El ghiriani (1) · Hospices Civils de Lyon (1) · Maastricht University Medical Center (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Milton S. Hershey Medical Center (1) · Nantes University Hospital (1) · Region Skane (1) · University Hospital, Strasbourg, France (1)
France (3) · Brazil (2) · Canada (1) · Egypt (1) · Netherlands (1)
Eduardo Borba, MD, PhD (1) · Eloisa Bonfa, MD, PhD (1) · Evelyne Vinet, MD/PhD (1) · Jehns Martineus, MD (1) · Naga S Salah, Professor (1) · Pieter van Paassen, PhD (1)
PMID 19911444, PMID 29297852, PMID 29346614, PMID 29409570, PMID 29540181, PMID 32087733, PMID 33658052, PMID 34459317, PMID 34843469, PMID 38017564, PMID 40578323